Day: January 21, 2021

ALLIANCE TRUST PLC                                  At the close of business Wednesday 20 January 2021:The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Par, was–       excluding income, 981.3p–       including income, 981.5p  The Company’s NAV per ordinary share, valued on a bid price basis with Debt at Fair Value, was–       excluding income, 966.6p–       including income, 966.8pFor further information, please contact: –NotesNet Asset Values are calculated in accordance with published accounting policies and AIC guidelines.The fair value of the Company’s fixed loan notes is calculated by reference to a benchmark gilt.

Medical records platform for psychedelic mental health to be available February 1 as a Plugin to the Ehave Dashboard.MIAMI, Jan. 21, 2021 (GLOBE NEWSWIRE) — Ehave, Inc. (OTC Pink: EHVVF) (the “Company”), a provider of digital therapeutics for the psychedelic and mental health sectors, announced today the availability of a breakthrough comprehensive solution for medical record exchange as the first plugin to its Ehave Dashboard. The medical record exchange plugin will allow patients to own their own healthcare records and work more closely with medical professionals and psychedelic researchers to target conditions that are poorly addressed by the healthcare system today, such as chronic diseases, treatment-resistant depression, and neurological disorders.According to Global Market Insights “the Electronic Health Record market...

News published on RÚV that Skeljungur´s subsidiary, P/F Magn, is in the process of being sold, is not correct.The article also referred to that the alleged sale is part of Skeljungur´s restructuring. No decision has been made by the company on its restructuring.

Frétt sem birtist á RÚV þess efnis að dótturfélag Skeljungs, P/F Magn, væri komið í söluferli, er ekki rétt.Þá er einnig vísað til þess í fréttinni að meint sala sé hluti af endurskipulagningu Skeljungs. Engar ákvarðanir hafa verið teknar af félaginu um endurskipulagningu þess.

UTRECHT, The Netherlands, and CAMBRIDGE, Mass., Jan. 21, 2021 (GLOBE NEWSWIRE) — Merus N.V. (Nasdaq: MRUS) (“Merus”, “we” and “our”), a clinical-stage oncology company developing innovative, full-length multispecific antibodies (Biclonics® and Triclonics™), today announced the pricing of an underwritten public offering of 4,848,485 common shares at a public offering price of $24.75 per share. The gross proceeds from the offering, before deducting underwriting discounts and commissions and estimated offering expenses, are expected to be approximately $120 million. In addition, Merus granted the underwriters a 30-day option to purchase up to an additional 727,272 common shares at the public offering price, less the underwriting discounts and commissions. All of the shares in the offering are to be sold by Merus.The offering is expected...

Press release, Copenhagen 21 January 2021US-based Tealium has developed a standard connector to Danish omnichannel marketing software company Agillic. With the connector, clients using Tealium, a Customer Data Platform (CDP), and Agillic can more easily create and execute highly personalised communication based on data from many disparate sources.With the standard connector, the synergy between the Tealium Customer Data Platform and Agillic enhances the capacity and intelligence of both systems, enabling a more personalised communication, which is recognised as impacting conversion rates and boosting the value of the marketing communication significantly.The standard connector substitutes a custom webhook and enables smoother data exchange between the Tealium CDP and the Agillic Platform. As the CDP collects vital data from many sources,...